Hone Bio Limited
11076788
Healthy
- No accounts filed in last 18 months (-5)
Details
Compliance
Last accounts
31/07/2024
total exemption full
Next accounts due
31/07/2026
Confirmation statement
Last: 21/11/2025
Due 05/12/2026
Industry
Officers
director · Since 22/11/2017
READER IN BIOMATERIALS
BRITISH,AUSTRALIAN · AUSTRALIA · Age 53
secretary · Since 29/10/2018
BRITISH
Also on 197 other boards
director · Since 15/03/2021
DIRECTOR
BRITISH · UNITED KINGDOM · Age 39
Also on 15 other boards
director · Since 11/03/2024
DIRECTOR
BRITISH · ENGLAND · Age 41
Also on 1 other board
director · Since 11/03/2024
DIRECTOR
BRITISH · ENGLAND · Age 66
Also on 1 other board
Persons with Significant Control
Former PSCs
Dr Adam Willis Perriman
Ceased 15/03/2021
CompanyRankvs 192+ SIC 72110 peers81
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/07/2023
Net Worth
£602k
Balance sheet strength
Cash
£544k
Cash in the bank
Net Current Assets
£400k
Working capital
Current Assets
£621k
Current Liabilities
£222k
Fixed Assets
£202k
Debtors
£77k
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2023 | 2.80 | -£1.3M |
| 2022 | 13.20 | -£1.4M |
| 2021 | 38.72 | +£3.0M |
| 2020 | 2.32 | +£154k |
| 2019 | 18.36 | — |
Derived from filed accounts. Not audited figures.